COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,390 Articles (22,816 medRxiv, 8,574 bioRxiv)

Most recent first Previous |  Page 1022: Articles 10211-10220  | Next

Temporary hold of mycophenolate boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients
Schrezenmeier, E., Rincon-Arevalo, H., Jens, A., Stefanski, A.-L., Hammett, C., Osmanodja, B., Koch, N., Zukunft, B., Beck, J., Oellerich, M., Pross, V., Stahl, C., Choi, M., Bachmann, F., Liefeldt, L., Glander, P., Schuetz, E., Bornemann-Kolatzki, K., Lopez del Moral, C., Schrezenmeier, H., Ludwig, C., Jahrdoerfer, B., Eckardt, K. U., Lachmann, N., Kotsch, K., Doerner, T., Halleck, F., Sattler, A., Budde, K.
10.1101/2022.01.05.21268478 — Posted: 2022-01-08
Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19
Pickering, C., Zhou, B., Xu, G., Rice, R., Huang, H., Pham, T., Shapiro, J., Cong, X., Chakraborty, S., Edwards, K., Reddy, S., Giurgis, F., Wang, T. T., Serie, D., Lindpaintner, K.
10.1101/2022.01.07.21267956 — Posted: 2022-01-08
Effectiveness of mRNA-1273 against SARS-CoV-2 omicron and delta variants
Tseng, H. F., Ackerson, B. K., Luo, Y., Sy, L. S., Talarico, C., Tian, Y., Bruxvoort, K., Tupert, J. E., Florea, A., Ku, J. H., Lee, G. S., Choi, S. K., Takhar, H. S., Aragones, M., Qian, L.
10.1101/2022.01.07.22268919 — Posted: 2022-01-08 Discussion: Onsite
Persistence of immunity and impact of a third (booster) dose of an inactivated SARS-CoV-2 vaccine, BBV152; a phase 2, double-blind, randomised controlled trial
Vadrevu, K. M., Ganneru, B., Reddy, S., Jogdand, H., Dugyala, R., Praturi, U., Sapkal, G. N., Yadav, P., Reddy, P., Verma, S., Singh, C., Redkar, S. V., Gillurkar, C. S., Kushwaha, J. S., Mohapatra, S., Bhate, A., Rai, S., Ella, R., Abraham, P., Prasad, S., Ella, K.
10.1101/2022.01.05.22268777 — Posted: 2022-01-08
BNT162b2 post-exposure-prophylaxis against COVID-19
Shemuelian, Z., Warszawer, Y., Or, O., Arbel-Alon, S., Giladi, H., Avgil Tsadok, M., Cohen, R., Shefer, G., Maruotti, A., Jona Lasinio, G., Galun, E.
10.1101/2022.01.07.22268869 — Posted: 2022-01-08 Discussion: Onsite
The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Black Queen rule
Colson, P., Gautret, p., Delerce, J., Chaudet, H., Pontarotti, P., Forterre, P., Tola, R., Bedotto, M., Delorme, L., LEVASSEUR, A., Lagier, J.-C., Million, M., Yahi, N., Fantini, J., La Scola, B., Fournier, P.-E., Raoult, D.
10.1101/2022.01.04.22268715 — Posted: 2022-01-08
Innate and adaptive immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in elderly people
Vitalle, J., Perez-Gomez, A., Ostos, F. J., Gasca-Capote, C., Jimenez-Leon, M. R., Bachiller, S., Rivas-Jeremias, I., Silva-Sanchez, M. d. M., Ruiz-Mateos, A., Lopez-Cortes, L. F., Rafii-El-Idrissi Benhnia, M., Ruiz-Mateos, E.
10.1101/2022.01.07.22268806 — Posted: 2022-01-08
Consensus on COVID-19 vaccination in pediatric oncohematological patients, on behalf of infectious working group of Italian Association of Pediatric Hematology Oncology
Cesaro, S., Muggeo, P., Zama, D., Cellini, M., Perruccio, K., Colombini, A., Carraro, F., Petris, M., Petroni, V., Mascarin, M., Baccelli, F., Soncini, E., Mura, R., Laspina, M., Decembrino, N., Burnelli, R., Frenos, S., Castagnola, E., Faraci, M., Meazza, C., Barzaghi, F., D'Amico, M. R., Capasso, M., Calore, E., Ziino, O., Barone, A., Compagno, F., Luti, L., Galaverna, F., De Santis, R., Brescia, L., Meneghello, L., Petrone, A., Giurici, N., Schumacher, F., Mercolini, F.
10.1101/2022.01.06.22268792 — Posted: 2022-01-08
Climate Surveys of Biomedical PhD Students and Training Faculty Members in the Time of Covid
Ramadoss, D., McCord, M. C., Horn, J. P.
10.1101/2022.01.06.475246 — Posted: 2022-01-07
Covariant Fitness Clusters Reveal Structural Evolution of SARS-CoV-2 Polymerase Across the Human Population
Wang, C., Elghobashi-Meinhardt, N., Balch, W. E.
10.1101/2022.01.07.475295 — Posted: 2022-01-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).